The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
Dieses Ebook kaufen – und ein weitere GRATIS erhalten!
Sprache Englisch ● Format EPUB ● ISBN 9781009336093 ● Verlag Cambridge University Press ● Erscheinungsjahr 2023 ● herunterladbar 3 mal ● Währung EUR ● ID 8807931 ● Kopierschutz Adobe DRM
erfordert DRM-fähige Lesetechnologie